HGEN
Income statement / Annual
Last year (2022), Humanigen, Inc.'s total revenue was $2.51 M,
a decrease of 30.07% from the previous year.
In 2022, Humanigen, Inc.'s net income was -$70.24 M.
See Humanigen, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$2.51 M |
$3.60 M |
$312,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$44,000.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$2.51 M
|
$3.60 M
|
$312,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$44,000.00
|
| Gross Profit Ratio |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
| Research and Development Expenses |
$55.21 M
|
$213.12 M
|
$72.71 M
|
$2.62 M
|
$2.22 M
|
$11.17 M
|
$10.45 M
|
$16.72 M
|
$26.57 M
|
$32.64 M
|
| General & Administrative Expenses |
$15.61 M
|
$23.25 M
|
$15.80 M
|
$6.33 M
|
$9.11 M
|
$7.87 M
|
$8.38 M
|
$14.30 M
|
$10.15 M
|
$8.31 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$15.61 M
|
$23.25 M
|
$15.80 M
|
$6.33 M
|
$9.11 M
|
$7.87 M
|
$8.38 M
|
$14.30 M
|
$10.15 M
|
$8.31 M
|
| Other Expenses |
$0.00
|
-$1.61 M
|
-$1,000.00
|
-$1,000.00
|
$324,000.00
|
$431,000.00
|
$125,000.00
|
-$213,000.00
|
-$154,000.00
|
-$39,000.00
|
| Operating Expenses |
$70.82 M
|
$236.37 M
|
$88.51 M
|
$8.94 M
|
$11.33 M
|
$19.03 M
|
$18.83 M
|
$31.02 M
|
$36.72 M
|
$40.95 M
|
| Cost And Expenses |
$70.82 M
|
$236.37 M
|
$88.51 M
|
$8.94 M
|
$11.33 M
|
$19.03 M
|
$18.83 M
|
$31.02 M
|
$36.72 M
|
$40.95 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$29,000.00
|
$88,000.00
|
$86,000.00
|
| Interest Expense |
$2.92 M
|
$2.26 M
|
$1.34 M
|
$1.35 M
|
$852,000.00
|
$3.06 M
|
$131,000.00
|
$842,000.00
|
$1.21 M
|
$1.09 M
|
| Depreciation & Amortization |
$492,000.00
|
-$1.61 M
|
-$1,000.00
|
-$1,000.00
|
$19,000.00
|
$48,000.00
|
$102,000.00
|
$197,000.00
|
$310,000.00
|
$298,000.00
|
| EBITDA |
-$67.81 M |
-$234.39 M |
-$88.20 M |
-$8.95 M |
-$10.99 M |
-$18.55 M |
-$18.60 M |
-$31.00 M |
-$36.47 M |
-$40.56 M |
| EBITDA Ratio |
-26.97
|
-65.2
|
-282.69
|
0
|
0
|
0
|
0
|
0
|
0
|
-921.91
|
| Operating Income Ratio |
-27.17
|
-64.75
|
-282.69
|
0
|
0
|
0
|
0
|
0
|
0
|
-929.75
|
| Total Other Income/Expenses Net |
-$2.43 M
|
-$3.88 M
|
-$1.34 M
|
-$1.35 M
|
-$673,000.00
|
-$2.96 M
|
-$8.19 M
|
-$1.03 M
|
-$1.28 M
|
-$1.04 M
|
| Income Before Tax |
-$70.73 M
|
-$236.65 M
|
-$89.54 M
|
-$10.29 M
|
-$12.00 M
|
-$21.99 M
|
-$27.02 M
|
-$35.38 M
|
-$38.00 M
|
-$41.95 M
|
| Income Before Tax Ratio |
-28.13
|
-65.83
|
-286.97
|
0
|
0
|
0
|
0
|
0
|
0
|
-953.36
|
| Income Tax Expense |
-$492,000.00
|
$2.26 M
|
$1.34 M
|
$1.35 M
|
$179,000.00
|
$3.49 M
|
$256,000.00
|
$629,000.00
|
$1.06 M
|
$1.05 M
|
| Net Income |
-$70.24 M
|
-$238.91 M
|
-$90.87 M
|
-$11.64 M
|
-$12.00 M
|
-$21.99 M
|
-$27.02 M
|
-$35.38 M
|
-$38.00 M
|
-$41.95 M
|
| Net Income Ratio |
-27.94
|
-66.46
|
-291.25
|
0
|
0
|
0
|
0
|
0
|
0
|
-953.36
|
| EPS |
-1.18 |
-4.08 |
-2.46 |
-0.52 |
-0.63 |
-7.34 |
-13.92 |
-42.88 |
-46.09 |
-69.13 |
| EPS Diluted |
-1.18 |
-4.08 |
-2.46 |
-0.52 |
-0.63 |
-7.34 |
-13.92 |
-42.88 |
-46.09 |
-69.13 |
| Weighted Average Shares Out |
$59.49 M
|
$58.53 M
|
$36.96 M
|
$22.36 M
|
$18.95 M
|
$3.00 M
|
$1.94 M
|
$825,001.00
|
$824,479.00
|
$606,760.00
|
| Weighted Average Shares Out Diluted |
$59.49 M
|
$58.53 M
|
$36.96 M
|
$22.36 M
|
$18.95 M
|
$3.00 M
|
$1.94 M
|
$825,001.00
|
$824,479.00
|
$606,760.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
